Alere has re-launched its Determine portfolio of products for the accurate and rapid diagnosis of infectious diseases, including the HIV 1/2 Ag/Ab Combo test, to fit within its new brand image.
Over the past year, the company (formerly called Inverness Medical) has rebranded many of its key products and services to the new Alere brand to ensure immediate recognition of their quality and generate confidence in the results they deliver.
Determine quickly and accurately detects the antibodies or antigens that indicate infection from HIV/AIDS, hepatitis B and syphilis at the point of care, producing results in just 15 to 20 minutes.
After purchasing the Determine portfolio from Abbott in 2005, Alere has developed these products further to ensure excellent diagnostic performance anywhere in the world.
A fourth-generation rapid diagnostic test, the Determine HIV 1/2 Ag/Ab Combo detects HIV infection 5-7 days earlier than HIV antibody-only tests.
Since the emergence of HIV/AIDS, it has become even more critical to diagnose early, not only to save lives, but also to prevent the spread of life-threatening infections.
Delivering early diagnosis, the simple two-step Determine tests require no power or water for use and they can be run with minimal training, as just a fingerstick of blood is needed for sample collection.
They can also be easily stored and transported.
